Results for tag: "Immunochemicals"

The Immunochemicals market is a subset of the Immune Disorders Drugs market, which focuses on the development of treatments for diseases related to the immune system. Immunochemicals are a type of drug that modulate the immune system, either by stimulating or suppressing it. These drugs are used to treat a variety of conditions, including autoimmune diseases, allergies, and cancer. Immunochemicals can be administered orally, intravenously, or topically, depending on the condition being treated. Immunochemicals are often used in combination with other treatments, such as chemotherapy or radiation therapy, to maximize the effectiveness of the treatment. Additionally, immunochemicals can be used to reduce the side effects of other treatments, such as reducing inflammation or suppressing the immune system. Some companies in the Immunochemicals market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more